ACM patients with high serum levels of oxLDL, including those carrying the TMEM43 mutation, have worse clinical phenotypes presenting as higher fat displacement of myocytes, ventricular dysfunction, and risk of having a severe, potentially lethal cardiac arrhythmia [113,126]. This evidence concerns the gene TMEM43 and chronic obstructive pulmonary disease.